Abstract
Introduction
Hypertension is a major cardiovascular risk factor in patients with type 2 or non-insulin-dependent diabetes w x mellitus 1 . Moreover, hypertension and type 2 diabetes often coexist, which has led to the hypothesis that insulin resistance may play a central role in the pathogenesis of w x both derangements 2 . However, the mechanisms by which insulin resistance affects blood pressure are unknown. Potential hypertensive effects of elevated insulin levels are w x increased sympathetic neural outflow 3 , augmented renal w x reabsorption of sodium 4 , and salt-sensitivity of blood w x pressure 5 . Finally, in insulin-resistant states such as type 2 diabetes and obesity, pressor responses to exogenous ) Ž .
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Ž . noradrenaline NA and angiotensin II AII are potentiw x ated 6 , suggesting enhanced responsiveness of the vascu-Ž . lar smooth muscle cell VSMC to vasoconstrictor stimuli. This enhanced responsiveness, in turn, could be related to w x abnormal VSMC calcium homeostasis 4 . On the other hand, increased pressor responsiveness could also be the consequence of impaired baroreceptor function, even withw x out any abnormalities in VSMC contractility 7 . Indeed, Baron and co-workers suggested that in obese insulin-resistant subjects the increased pressor response to exogenous NA is based upon a defect in baroreceptor function w x 8 .
To our knowledge, no studies have been performed which address both local and systemic pressor responsiveTime for primary review 33 days.
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( )ness to exogenous NA in type 2 diabetes. Therefore, in the present study we assessed in the same type 2 subjects and healthy volunteers not only blood pressure and heart rate Ž . as a measure of baroreceptor activity responses to systemic infusions of NA, but also the vasoconstrictor responses of forearm resistance arterioles to local infusion of NA. In a separate group of patients and controls venous responsiveness to local NA was determined. Only normoalbuminuric subjects were studied, as most microalbuminuric patients have signs of autonomic neuropathy, which in itself could modify NA pressor responsiveness w x 9 . Furthermore, all participants were non-obese, as obesity may also enhance pressor responses to exogenous NA w x 10 . Finally, all subjects were normotensive, as we wanted to avoid exaggerated pressor responses due to hypertension-induced media hypertrophy.
Methods

Subjects
Control subjects were recruited by advertisements in local newspapers, while patients with type 2 diabetes were recruited from the outpatient department of the University Hospital Maastricht and by advertisements. Type 2 diabetes was defined as the onset of diabetes after the age of 40 years, initially treated by diet andror oral anti-diabetic medication. Supine blood pressure in these patients did not exceed 160r90 mmHg. None of the subjects studied had evidence of cardiovascular disease, nephropathy, hyperlipidaemia or neuropathy on physical examination or routine biochemical screening. Serum creatinine levels were all below 100 mmol l y1 . Microalbuminuria, defined as an Ž . urinary albumin excretion UAE of 30-300 mgr24 h, was excluded in all patients. The presence of autonomic Ž neuropathy was excluded by measuring heart rate R-R . interval variations during deep breathing and Valsalva manoeuvre, and heart rate and blood pressure responses to standing under standardized conditions as described by w x Ewing and Clarke 11 . None of the patients had symptoms Ž . or signs abnormal tendon reflexes and vibration sense of distal polyneuropathy. Metabolic control in the type 2 patients was achieved by tolbutamide in eight patients, by gliclazide in three patients, by glimeperidine in one patient, by glibenclamide in three patients, while two patients were treated with diet only. None of the type 2 patients or Ž the healthy volunteers used any medication including . NSAID's for at least 4 weeks preceding the study, except for oral antidiabetic drugs by the diabetic patients.
All subjects were instructed to avoid caffeine-containing drinks, smoking and alcohol for 12 h preceding the studies. Experiments were performed after an overnight fast and on the morning of the experiments the type 2 patients omitted their anti-diabetic medication. All subjects gave written informed consent and the study was approved by the Ethical Review Committee of the University Hospital Maastricht. The investigations conformed with the principles outlined in the Declaration of Helsinki.
Protocol
Two different studies were performed in 17 healthy volunteers with a negative family history for diabetes or hypertension and in 17 type 2 diabetic patients. In the first study NA was infused intravenously to evaluate the effect of NA on blood pressure, heart rate and forearm blood Ž . flow FBF in 10 type 2 patients and 10 healthy volunteers Ž . study I, FBF and pressor response . Subsequently, the vasoconstrictor effect of NA, administered into the brachial artery of the non-dominant arm, on FBF was determined in these same patients. In the second study the vasoconstrictor response of the dorsal hand vein to local infusion of NA was evaluated in 13 type 2 patients and 14 healthy Ž . volunteers study II, hand vein . Seven healthy volunteers and 5 type 2 patients participated in both studies.
Study I
After local anaesthesia by 1.5 ml 1% lidocaine, a 20 Ž . gauge arterial catheter Arrow, Reading, PA, USA was inserted retrogradely into the brachial artery of the nondominant arm for local NA infusions and blood pressure measurements. The catheter was kept patent with saline.
Ž . Mean arterial pressure MAP was measured using a Ž . Hewlett Packard 78205C monitor Boeblingen, Germany . FBF was determined simultaneously in both arms by ECG-triggered strain gauge venous occlusion plethysmog-Ž raphy Periflow, Janssen Scientific Instruments, Beerse, . w x Belgium as described earlier 12 . The hand circulation was excluded during FBF measurements by inflating a wrist cuff to suprasystolic pressure, starting one minute before each FBF measurement. Hence, FBF measurements w x represent predominantly muscle blood flow 13 . Heart rate was derived from the ECG. All signals were stored on the hard disk of a personal computer by means of a custom build data acquisition system. Subjects were studied supine Ž . in a temperature-controlled room with a mean "SD temperature of 24.0 " 0.58C. The hand vein was used as an in-vivo model of an isolated vessel to study the interaction between the endothelium and the VSMC in response to NA. With this model local vascular responsiveness, independent of systemic and reflex responses, can be measured by infusion of minute amounts of NA. Subjects were studied supine in a Ž . temperature-controlled room with a mean "SD temperature of 26.0 " 0.58C, in order to minimize vascular tone. In the non-dominant arm a dorsal hand vein was cannulated with a 23-Gauge butterfly needle. This arm was resting on a padded support, 308 above the horizontal, so that the vein, which was above heart level, was completely collapsed. A cuff was attached around the upper arm. Changes Ž in vein diameter were measured using the LVDT model . 100 HMR, Schaevitz Engineering, Pennsauken, NJ and an Ž . ATA signal conditioner Schaevitz Engineering . The LVDT was mounted on the back of the hand using a tripod. The tip of the steel core of the LVDT was positioned over the centre of the vein approximately 1 cm proximal to the tip of the butterfly needle. After an acclimatization period of 30 min, three baseline measurements of venous distension were performed with a cuff pressure of 40 mmHg. The difference between the collapsed and fully distended readings represented the maximum vein diameter, i.e. the diameter at 0% constriction. Subsequently, a cumulative stepped infusion of NA, 0.3-160 ng.min y1 , dissolved in 0.9% saline was delivered into Ž the hand vein by a syringe driver pump Terufusion sy-. ringe pump model STC-521, Terumo, Tokyo, Japan at an infusion rate of 0.1 ml.min y1 . Each dose of NA was infused during 7 min with inflation of the cuff during the last 2 min. Vein diameter was measured during the 7th minute of the infusion. Prior to the present studies the variability of the ED50 to NA was evaluated in healthy Ž . volunteers n s 18 . The within-day coefficient of variance of the ED50 in these experiments was 28%, which is w x compatible with that in other studies 15 .
Assays
Fasting blood glucose concentration was measured by the glucoxidase method, cholesterol, triglyceride, creatinine by commercial methods, HbA1c using the Diamat HPLC analyzer. Serum insulin was determined by a modi-Ž . fied RIA assay Pharmacia Upjohn, Uppsala, Sweden to exclude cross reactivity with human pro-insulin and with auto-antibodies. Plasma catecholamines were determined by HPLC followed by fluorescence detection. Microalbuminuria was measured by a commercial immuno-turbidi- 
Statistics
As the data were not distributed normally, all data are expressed as median values and interquartile ranges unless Ž . Ž . Fig. 2 . Heart rate HR response to changes in mean arterial pressure MAP in healthy volunteers and type 2 patients. BPM: beats per minute. Mean regression line and 95% confidence interval. 
Results
As expected HbA1c, fasting blood glucose, and serum Ž insulin levels were higher in the type 2 patients p -0.01, . p -0.05, and p -0.05, respectively, Table 1 . Furthermore, no differences were observed between the groups in study I and II, except for triglyceride levels, which were Ž higher in type 2 patients than in healthy volunteers p -. 0.05, Table 1 .
Study I
Pressor and FBF response to systemic NA
Systemic NA infusion resulted in a dose dependent increase in blood pressure in all subjects, both healthy Ž . volunteers Friedman p -0.001, Fig. 1 and type 2 pa-Ž . tients Friedman p -0.001, Fig. 1 . The increase in blood pressure was accompanied by a decrease in heart rate in Ž the healthy volunteers and the type 2 patients Friedman Ž . sensitivity to noradrenaline in healthy volunteers ' and in type 2 diabetic patients B . As no significant correlations were observed in the diabetic Ž . patients, only the correlations with 95% confidence interval in the healthy volunteers is shown in both panels. Slope: the slope of the MAP response to NA. MAP: mean arterial pressure. 
Local intra-arterial NA infusion
At the start of the intra-arterial infusions FBF did not differ between healthy volunteers and type 2 patients: 3.2 Ž . Ž .
y1 y1
2.3-3.6 vs. 2.6 1.5-3.0 ml.100 ml .min , p s 0.15. Whereas blood pressure and heart rate did not change during intrabrachial NA infusion, this infusion caused a dose-dependent decrease in FBF-index in all subjects, both Ž . healthy volunteers Friedman p -0.001, Fig. 4 
Discussion
The present study clearly indicates that the systemic pressor response to NA is increased in normotensive nonobese type 2 patients without microalbuminuria, thus conw x firming earlier studies 6,20,21 . Moreover, in the healthy volunteers, but not in the type 2 patients, pressor responsiveness to NA was correlated with basal insulin levels and relative insulin resistance. Although pressor responsiveness w x to NA can be modified by sodium depletion 22 , we were merely interested in the localization of the defect that determines the enhanced responsiveness. Therefore, all subjects continued their habitual diet.
Theoretically, the difference in systemic pressor response to exogenous NA could be related to a decreased clearance rate of the administrated NA, as can be observed w x in obese insulin-resistant subjects 8 . However, Tack et al.
w 3 x failed to find, in a recent study using the H -noradrenaline tracer method, differences in total body clearance and forearm NA kinetics between normotensive type 2 patients w x and healthy volunteers 23 . Moreover, in the present study circulating plasma levels inducing a MAP rise of 20 mmHg were clearly lower in the type 2 patients, indicating NA enhanced pressor responsiveness. Thus it is unlikely ( )that our results are due to reduced NA clearance in the type 2 patients.
NA raises arterial pressure primarily by increasing sysw x temic vascular resistance 9 . At the same time, cardiac output falls as a consequence of baroreceptor stimulation w x 7 . From a theoretical point of view, therefore, an increased pressor responsiveness in type 2 diabetes could be related to impaired baroreceptor functioning. Such a mechanism has, indeed, been proposed by Baron and co-workers w x 8 . However, baroreceptor responsiveness to the NA induced rise in MAP was not different between type 2 diabetic subjects and healthy volunteers in the present study. We assessed baroreceptor performance from the relationship between the rise in MAP and the concurrent reduction in heart rate. For any given rise in blood pressure, we found that the fall in heart rate was similar in type 2 patients and controls, suggesting that in our patients baroreceptor function was intact. This could be the result of the meticulous selection of our type 2 patients. Since autonomous neuropathy was excluded in the type 2 patients, it is unlikely that the sympathetic nervous system was defective in these patients. Thus, our findings led us to Ž conclude that an enhanced vascular reactivity or sensitiv-. ity was the main reason for the increased pressor responses in type 2 diabetes.
Our data further suggest that the increased pressor response is not the result of a generalized vascular defect. First of all, systemic administration of NA had no effect on FVR in type 2 patients, despite an adequate rise in arterial NA levels. Similar findings have been obtained in healthy subjects in whom FVR also remained unaltered or even w x decreased during systemic NA infusion 24,25 . Secondly, local administration of NA elicited similar vasoconstrictor responses of forearm arterioles in type 2 patients and controls. It could be argued that during intrabrachial infusion far higher NA levels were reached in the forearm vascular bed in comparison to the levels reached during the systemic infusion. However, estimated NA levels during the local infusion of 0.1 mgrmin are similar to the levels measured during the highest dose of systemic NA administration. Finally, local administration of NA in a dorsal hand vein showed similar venoconstrictor responses in type 2 patients and controls. From these data we conclude that the increased systemic pressor response to NA is not related to an exaggerated vascular responsiveness in skeletal muscle resistance arterioles or peripheral veins. It is tempting to speculate, therefore, that type 2 patients Ž display an enhanced responsiveness of their visceral i.e.
. splanchnic andror renal circulation. However, currently no data are available about the responsiveness of the splanchnic bed or renal vasculature to NA in type 2 diabetes.
Several mechanisms could be involved in the enhanced NA pressor responsiveness in type 2 diabetes. Firstly, treatment with sulphonylurea drugs could have influenced w x NA responsiveness in the type 2 patients 26 . These drugs inhibit ATP-sensitive potassium channels, thereby stimulating Ca 2q influx and possibly enhancing vasoconstrictor w x Ž . responses 27 . However, in study I pressor response only one patient was using glibenclamide, which seems to be the only sulphonylurea drug with such vascular effects in w x therapeutic concentrations 28 . Secondly, glucose and triglyceride levels were different. Alterations in vascular noradrenergic responsiveness have been described in hyperglycemic, streptozotocin induced diabetic rats, a model w x for type 1 diabetes 29 . However, studies in healthy volunteers showed that acute elevation of glucose and triglycerides have no effect on NA responsiveness w x 12,30,31 , suggesting that hyperglycaemia and hypertriglyceridaemia are not important factors in NA pressor responsiveness. Thirdly, it is likely that the type 2 patients Ž . had elevated circulating levels of free fatty acids FFA . Some data suggest that elevated FFA levels, which were not determined in the present study, could enhance the w x a-adrenergic responsiveness in man 32 . Further studies are needed to assess the potential role of FFA in the enhanced pressor response in type 2 diabetes.
Apart from sulfonylurea treatment and differences in metabolic factors, hyperinsulinaemia andror insulin resistance could play a role in the enhanced pressor response in type 2 diabetes. A striking finding in the present study were the strong correlations between NA pressor responsiveness and both basal insulin levels and calculated insulin resistance in healthy volunteers. Several authors suggest that hyperinsulinaemia or insulin-resistance is associw x ated with enhanced VSMC contractility 33 . This enhanced constrictor responsiveness could contribute to the enhanced NA pressor responses and could promote the w x development of hypertension 34 . Insulin affects transmembrane calcium transport by several mechanisms and there is some evidence which suggests that insulin resistance is associated with an increase in intracellular calcium w x 33 . This rise in intracellular calcium could result in enhanced VSMC contractile responsiveness to NA and w x other agonists 33 .
Insulin also stimulates the production of endothelium-Ž . derived nitric oxide EDNO , thereby increasing peripheral w x blood flow 35,36 . In type 2 diabetics EDNO production and action are impaired in several vascular beds, including w x that of the forearm 37,38 . In-vitro, EDNO attenuates NA w x constrictor responses 39 and it has been suggested that the impaired EDNO production in type 2 diabetes could w x contribute to enhanced VSMC contractility 40 . However, Ž . as reported earlier in this journal acute hyperinsulinaemia induces vasodilatation in the forearm, without any effects w x on NA constrictor responses 36 . Whether this also holds true for other vascular beds remains to be determined. As insulin levels in the splanchnic bed are up to three times w x higher than in peripheral vessels 41 , this vascular bed is exquisitely exposed to long-term hyperinsulinaemia.
In contrast to the healthy volunteers, no correlation was observed between basal serum insulin levels and calculated ( )relative insulin resistance in the type 2 patients. At present this discrepancy is difficult to explain. It is unlikely that the increased insulin levels in the type 2 patients were Ž . partly based upon a rise in proinsulin, as a specific insulin assay was used. Relative insulin resistance was w x calculated using basal insulin and glucose levels 16 . Estimation of insulin resistance could, therefore, have been less accurate in the type 2 patients. Further studies, in Ž which insulin resistance is quantified in more detail e.g.
. the hyperinsulinemic-euglycemic clamp technique , are needed to determine the relationship between insulinrinsulin resistance and NA pressor responsiveness in type 2 patients. Alternatively, if the enhanced pressor responsiveness is based upon a severe defect in EDNO production, as discussed above, this could have resulted in a loss of association between insulin and pressor responsiveness in the type 2 patients.
In conclusion, our data suggest that the enhanced pressor responses to NA in type 2 diabetic patients are not based upon enhanced constrictor responses in the skeletal arterioles and veins. The potential role of the visceral circulation in blood pressure regulation in these patients needs to be explored. 
